期刊文献+

盐酸氨基酮戊酸介导的光动力疗法增高U251细胞蛋白酶体的表达 被引量:1

Photodynamic therapy mediated with 5-aminolevulinic acid enhances the expression of proteasomes in glioma cell line U251 cells
下载PDF
导出
摘要 目的探讨盐酸氨基酮戊酸(5-ALA)做为光敏剂的光动力疗法(PDT)对人胶质瘤细胞株U251细胞的杀伤效应及其对U251细胞蛋白酶体亚基低分子量多肽(LMP)2、7表达的影响。方法培养U251细胞,利用细胞计数药盒确定的5-ALA-PDT对U251细胞半抑制剂量为试验条件。分别收集5-ALA-PDT处理后3、6、9、12、15、18、21和24 h及对照组U251细胞LMP2和LMP7,RNA与蛋白质,分别行实时PCR、Western Blot分析。结果强度为20 mw/cm2激光照1、2、3和4 min后U251细胞抑制率分别为11.18%、19.6%、48.62%、66.21%。以强度为20 mw/cm2照射3 min为条件,照射后3、6、9、12、15、18、21和24 h,U251细胞蛋白酶体亚基LMP2、LMP7蛋白和mRNA表达水平均明显高于对照组(P<0.01)。结论以5-ALA为光敏剂的PDT能有效抑制体外培养U251细胞生长,并促进蛋白酶体的表达。 Objective To investigate the effect of photodynamic therapy (PDT) mediated with 5-aminolevulinic acid (5-ALA) on the expression of the proteasomes in glioma cell line U251 cells. Methods U251 cells were cultured. The half inhibiting concentration of 5-ALA for U251 cells was determined by Counting Kit-8(CCK-8) technique. The expressions of mRNA and protein of proteasomes including low moleculasr weight polypeptide (LMP)2 and 7 in U251 cells were determined respectively by reahime PCR and western blot 3, 6, 9, 12, 15, 18, 21 and 24 hours after PDT. Results The inhibitory rates for U251 cells growth were 11.18%, 19.6%, 48.62% and 66.2% respectively after PDT at 20 mw/cm2 radiation intensity for 1, 2, 3 and 4 minutes. The levels of LMP2 and LMP7 mRNA expressions were significantly higher in U251 cells 3, 6, 9 and 12 hours after PDT than those in the control group (P〈0.01). The levels of LMP2 and LMP7 proteins expressions were significantly higher in u25i cells 6, 9, 12, 15, 18, 21 and 24 hours after PDT than those in the control group (P〈0.01). Conclusion PDT mediated with 5-ALA can inhibit the growth of the U251 ceils and upregulate proteasomes expression in U251 cells.
出处 《中国临床神经外科杂志》 2012年第3期154-157,共4页 Chinese Journal of Clinical Neurosurgery
基金 国家自然科学基金资助项目(NO:81072081)
关键词 胶质瘤 U251细胞 盐酸氨基酮戊酸 光动力疗法 蛋白酶体 5-aminolevulinic acid Photodynamic therapy Glioma Proteasomes Expression
  • 相关文献

参考文献12

  • 1Burton EC,Prados MD.Malignant gliomas[J].Curr TreatOptions Oncol,2000,1(5):459-468.
  • 2Seifert U,Bialy LP,Ebstein F,et al.Immunoproteasomespreserve protein homeostasis upon interferon-induced oxi-dative stress[J].Cell,2010,142(4):613-624.
  • 3Zhang SY,Li JL,Xu XK,et al.HMME-based PDT restoresexpression and function of transporter associated with anti-gen processing 1(TAP1)and surface presentation of MHCclass I antigen in human glioma[J].J Neurooncol,2011,105(2):199-210.
  • 4Mathews MS,Angell-Petersen E,Sanchez R,et al.The ef-fects of ultra low fluence rate single and repetitive photody-namic therapy on glioma spheroids[J].Lasers Surg Med,2009,41(8):578-584.
  • 5Castano AP,Mroz P,Hamblin MR.Photodynamic therapyand anti-tumour immunity[J].Nat Rev Cancer,2006,6(7):535-545.
  • 6Strehl B,Seifert U,Kruger E,et al.Interferon-gamma,thefunctional plasticity of the ubiquitin-proteasome system,and MHC classⅠantigen processing[J].Immunol Rev,2005,207:19-30.
  • 7Kloetzel PM.Antigen processing by the proteasome[J].NatRev Mol Cell Biol,2001,2(3):179-187.
  • 8Raffaghello L,Nozza P,Morandi F,et al.Expression andfunctional analysis of human leukocyte antigen classⅠantigen-processing machinery in medulloblastoma[J].Can-cer Res,2007,67(11):5471-5478.
  • 9Lou Y,Basha G,Seipp RP,et al.Combining the antigenprocessing components TAP and Tapasin elicits enhancedtumor-free survival[J].Clin Cancer Res,2008,14(5):1494-1501.
  • 10Yewdell JW.The seven dirty little secrets of major histo-compatibility complex class I antigen processing[J].Immu-nol Rev,2005,207:8-18.

二级参考文献8

  • 1王煜,牛洪泉,董芳永,董震,柳再明,雷霆,薛德麟.大鼠树突状细胞疫苗治疗脑胶质瘤的实验研究[J].中国临床神经外科杂志,2005,10(2):115-117. 被引量:12
  • 2Fong L, Engleman EG. Dendritic cells in cancer immunotherapy [J]. Annu Rev Immunol, 2000, 18: 245-273.
  • 3Chapuis F, Rosenzwaig M, Yagello M, et al. Differentiation of human dendrtic cells from monocytes in vitro [J]. Eur J Immunol, 1997, 27: 431-441.
  • 4Muessel MJ, Klein RM, Wilson AM, et al . Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronaI degeneration, attenuates microglial activation, and alters expression of cell death molecules [J]. Brain Res Mol Brain Res, 2002, 103(1-2): 12-27.
  • 5Banchereau J, Steinman RM SD. Dendritic cells and the control of immunity [J]. Nature, 1998, 392: 245-252.
  • 6Li L, Liu D, Hutt-Fletcher L, et al . Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4 [J]. Blood, 2002, 99(10): 3725-3734.
  • 7Cavanagh LL, Saal RJ, Grimmett KL, et al. Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation [J]. Blood, 1998, 92(5): 1598-1607.
  • 8王小沛,冯凯,朱玲,裴蕾.四种不同来源的树突状细胞的性能比较研究[J].白血病.淋巴瘤,2003,12(4):199-201. 被引量:1

共引文献2

同被引文献15

  • 1Lankat-Buttgereit B, Tampe R. The transporter associated with antigen processing: function and implications in hu- man diseases [ J ]. Physiol Rev,2002,82 ( 1 ) : 187-204.
  • 2Charron D. Immunogenetics today: HLA, MHC and much more [ J ]. Curr Opin Immunol, 2005,17 (5) : 493-497.
  • 3Satoh E, Mabuchi T, Satoh H, et al. Reduced expression of the transporter associated with antigen processing 1 mol- ecule in malignant glioma cells, and its restoration by in- terferon-γ and-β [ J ]. J Neurosurg, 2006, 104 ( 2 ) : 264- 271.
  • 4Kaczmarek M, Frydrychowicz M, Rubis B, et al. Analysis of expression of MHC class Ⅰ molecules and TAP genes in malignant human cell lines [ J ]. Folia Histochem Cytobiol, 2007,45(3) :205-214.
  • 5Alimonti J, Zhang Q J, Gabathuler R, et al. TAP expres- sion provides a general method for improving the recogni- tion of malignant cells in vivo [ J ]. Nat Biotechnol, 2000, 18(5) :515-520.
  • 6Ma W, Lehner PJ, Cresswell P, et al. Interferon-γ rapid- ly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells [ J ]. J Biol Chem, 1997,272 ( 26 ) : 16585-16590.
  • 7Tao J, Li Y, Liu YQ, et al. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity [ J]. J Invest Dermatol,2008,128 (8) : 1991-1996.
  • 8Bartosch B, Cosset FL. Strategies for retargeted gene de- livery using vectors derived from lentiviruses [ J ]. Curt Gene Ther,2004,4(4) :427-443.
  • 9Restifo NP, Esquivel F, Kawakami Y, et al. Identifica- tion of human cancers deficient in antigen processing[ J ]. J Exp Med, 1993,177 ( 2 ) : 265-272.
  • 10Flajnik MF, Kasahara M. Comparative genomics of the MHC: glimpses into the evolution of the adaptive immune system [ J ]. Immunity,2001,15 (3) : 351-362.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部